Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $9.29 in the prior trading day, Alignment Healthcare Inc (NASDAQ: ALHC) closed at $9.36, up 0.75%. In other words, the price has increased by $0.75 from its previous closing price. On the day, 1.42 million shares were traded. ALHC stock price reached its highest trading level at $9.54 during the session, while it also had its lowest trading level at $9.17.
Ratios:
Our goal is to gain a better understanding of ALHC by taking a closer look at its different ratios. In the meantime, Its Debt-to-Equity ratio is 1.30 whereas as Long-Term Debt/Eq ratio is at 1.30.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, BofA Securities on May 30, 2024, Upgraded its rating to Buy and sets its target price to $11 from $7.75 previously.
On May 30, 2024, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $10.
Piper Sandler Upgraded its Neutral to Overweight on May 08, 2024, whereas the target price for the stock was revised from $6 to $8.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 19 ’24 when Freeman Robert Thomas sold 38,858 shares for $10.01 per share. The transaction valued at 388,790 led to the insider holds 414,429 shares of the business.
Maroney Dawn Christine sold 36,700 shares of ALHC for $367,209 on Jul 19 ’24. The President, Markets now owns 1,816,097 shares after completing the transaction at $10.01 per share. On Jul 18 ’24, another insider, Freeman Robert Thomas, who serves as the Chief Financial Officer of the company, sold 44,042 shares for $10.00 each. As a result, the insider received 440,433 and left with 453,287 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALHC now has a Market Capitalization of 1789613184 and an Enterprise Value of 1659460736. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.89 while its Price-to-Book (P/B) ratio in mrq is 13.67. Its current Enterprise Value per Revenue stands at 0.824 whereas that against EBITDA is -14.883.
Stock Price History:
Over the past 52 weeks, ALHC has reached a high of $10.16, while it has fallen to a 52-week low of $4.46. The 50-Day Moving Average of the stock is 16.33%, while the 200-Day Moving Average is calculated to be 35.21%.
Shares Statistics:
The stock has traded on average 996.62K shares per day over the past 3-months and 1307550 shares per day over the last 10 days, according to various share statistics. A total of 188.95M shares are outstanding, with a floating share count of 89.31M. Insiders hold about 53.29% of the company’s shares, while institutions hold 40.23% stake in the company. Shares short for ALHC as of 1721001600 were 4325700 with a Short Ratio of 4.34, compared to 1718323200 on 4028337. Therefore, it implies a Short% of Shares Outstanding of 4325700 and a Short% of Float of 3.54.
